Mecasermin (Recombinant IGF-1) from United States
Mecasermin (Recombinant IGF-1) is a recombinant insulin-like growth factor 1, a structural analogue closely related to the somatotropin/IGF-1 axis. Although it mediates the effects of somatotropin, it is a distinct polypeptide hormone with its own biological activity. It is used primarily for treating severe primary IGF-1 deficiency, and its classification under somatotropin is arguable due to its distinct structure and function.
Duty Rate — United States → Canada
Import Tips
• Confirm the product's active ingredient and intended use with the manufacturer, as IGF-1 may be classified differently if used for non-hormonal purposes
• Provide a detailed product monograph to the CBSA to support classification as a polypeptide hormone
• Check if a Drug Identification Number (DIN) or Notice of Compliance is required for importation into Canada